2JACKSON J P WAUGH W.膝关节外科学[M].北京:中国医药科学技术出版社,1990.125-132.
3[1]Choo JX,Cheah J. Efectiveness of clinical pathways in improving. The Quality of Care. Singapore Nursing Journal,1999,27:8-11.
4[2]Healy WL,Iorio R. Impact of cost reduction programs on short-term patient outcome and hospital cost of total knee arthroplasty. Bone Joint Surg Am, 2002 ,84-A(3):384-393.
5[3]Thomas R, Gadacz MD. General surgical clinical pathways: an introduction. The American Surgeon, 1997, 63(1):107-110.
6[5]Clinical pathways for general surgeons: cholecystectomy, open W/O CBDE. The American Surgeon, 1998, 64(3): 289- 292.
7[7]Restuccia JD, Paync SMC, Lenhart G, et al. Assessing the appropriateness of hospital utilization to improve efficiency and competitive position. Health Care Managament Review,1987,12: 17-27.
8HOFMANN P A. Critical path method: an important tool for coordinating clinical care[J]. Journal on Quality Improvement, 1993,19(7) : 235 - 246.
9THOMAS R,GADACZ M D. General surgical clinical pathways:an introduction [J]. The American Surgeon, 1997, 63 (1): 107 -110.
2Chutia H, Ruram AA, Bhattacharyya H, et al. Association of secondary hyperparathyroidism with hemoglobin level in patients with chronic kidney disease[J]. J Lab Physicians, 2013, 5 (1) : 51-54.
3Dheerendra PC, Sakhuja V, Kohli HS, et at. Efficacy and safety of oral doxercalciferol in the management of secondary hyperparathyroidism in chronic kidney disease stage 4[J]. Indian J Nephrol, 2013, 23 (4) : 271-275.
4Chauhan V, Kelepouris E, Chauhan N, et al. Current concepts and management strategies in chronic kidney disease-mineral and bone disorder[J]. South Med J, 2012, 105 (9) : 479-485.
5Park JH, Kim SB, Shin HS, et al. Spontaneous and serial rupture of both Achilles tendons associated with secondary hyperparathyroidism in a patient receiving long-term hemodialysis[J]. Int Urol Nephrol, 2013, 45 ( 2 ) : 587-590.
6Sagliker Y, Balal M, Sagliker Ozkaynak P, et al. Sag- liker syndrome., uglifying human face appearance in late and severe secondary hyperparathyroidism in chro- nic renal failure. Semin Nephrol, 2004, 24(5): 449- 455.
7Uzel A, Uzel I, Sagliker Y,et al. Cephalometric eval- uation of patients with Sagliker syndrome., uglifying human face appearance in severe and late secondary hy- perparathyroidism in chronic renal failure patients. J Ren Nutr, 2006,16(3) :229-232.
8Giray S, Sagliker Y, Yildiz I, et aL Neurologic mani- festations in Sagliker syndrome: uglifying human face appearance in severe and late secondary hyperparathy- roidism in chronic renal failure patients. J Ren Nutr, 2006,16 (3) : 233-236.
